Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1967 1
1968 1
1969 4
1970 1
1972 1
1973 2
1975 3
1976 2
1977 5
1978 2
1979 2
1980 2
1981 3
1982 1
1983 3
1984 1
1985 1
1986 4
1987 3
1988 1
1989 1
1990 4
1991 7
1992 5
1993 6
1994 5
1995 3
1996 13
1997 17
1998 22
1999 11
2000 20
2001 12
2002 13
2003 17
2004 12
2005 16
2006 13
2007 11
2008 12
2009 20
2010 18
2011 25
2012 30
2013 19
2014 10
2015 9
2016 18
2017 20
2018 17
2019 17
2020 23
2021 25
2022 19
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

510 results

Results by year

Filters applied: . Clear all
Page 1
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Yamamura S, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Kawada N, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Among authors: yamamura s. Clin Gastroenterol Hepatol. 2023 Feb;21(2):370-379. doi: 10.1016/j.cgh.2022.01.002. Epub 2022 Jan 17. Clin Gastroenterol Hepatol. 2023. PMID: 35051649
Interaction and cross-talk between non-coding RNAs.
Yamamura S, Imai-Sumida M, Tanaka Y, Dahiya R. Yamamura S, et al. Cell Mol Life Sci. 2018 Feb;75(3):467-484. doi: 10.1007/s00018-017-2626-6. Epub 2017 Aug 24. Cell Mol Life Sci. 2018. PMID: 28840253 Free PMC article. Review.
Fluorophore-PNA-Quencher/Quencher-DNA probe for miRNA detection.
Tabara K, Watanabe K, Shigeto H, Yamamura S, Kishi T, Kitamatsu M, Ohtsuki T. Tabara K, et al. Among authors: yamamura s. Bioorg Med Chem Lett. 2021 Nov 1;51:128359. doi: 10.1016/j.bmcl.2021.128359. Epub 2021 Sep 14. Bioorg Med Chem Lett. 2021. PMID: 34534675
Tumor cell-derived ANGPTL2 promotes β-catenin-driven intestinal tumorigenesis.
Horiguchi H, Kadomatsu T, Yumoto S, Masuda T, Miyata K, Yamamura S, Sato M, Morinaga J, Ohtsuki S, Baba H, Moroishi T, Oike Y. Horiguchi H, et al. Among authors: yamamura s. Oncogene. 2022 Aug;41(33):4028-4041. doi: 10.1038/s41388-022-02405-8. Epub 2022 Jul 13. Oncogene. 2022. PMID: 35831580
510 results